Bahagia Willibrordus Maria Nainggolan

Mr. Bahagia Willibrordus Maria Nainggolan

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Harapan HarapanHarapan Harapan
Harapan Harapan
RFRaisha Fathima
Raisha Fathima
HKHendrix Indra Kusuma
Hendrix Indra Kusuma
SASamsul Anwar
Samsul Anwar
WNWidhy Yudistira Nalapraya
Widhy Yudistira Nalapraya
Mudatsir MudatsirMudatsir Mudatsir
Mudatsir Mudatsir
Obtaining a booster dose of coronavirus disease 2019 (COVID-19) vaccine is required to maintain the protective level of neutralizing antibodies and therefore herd immunity in the community, and the success of booster dose programs depends on public acceptance. The aim of this study was to determine the acceptance of a booster dose of COVID-19 vaccine and its drivers and barriers in Indonesia. A cross-sectional survey was conducted in the provinces of Indonesia between 1 and 15 August 2022. Individuals who completed the primary series of the COVID-19 vaccine were asked about their acceptance of a booster dose. Those who refused the booster dose were questioned about their reasons. A logistic regression was used to determine the determinants associated with rejection of a booster dose of COVID-19 vaccine. A total of 2935 respondents were included in the final analysis. With no information on the efficacy and safety of the COVID-19 vaccine, 95% of respondents agreed to receive a booster dose if it were provided for free by the government. This acceptance was reduced to only 50.3% if the vaccine had a 75% efficacy with a 20% chance of side effects. The adjusted logistic regression analysis indicated that there were eight factors associated with the rejection of the booster dose: age, marital status, religion, occupation, type of the first two vaccines received, knowledge regarding the importance of the booster dose, belief that natural immunity is sufficient to prevent COVID-19 and disbelief in the effectiveness of the booster dose. In conclusion, the hesitancy toward booster doses in Indonesia is influenced by some intrinsic factors such as lack of knowledge on the benefits of the booster dose, worries regarding the unexpected side effects and concerns about the halal status of the provided vaccines and extrinsic determinants such as the effectiveness and safety of the vaccine. These findings suggest the need for more campaigns and promotions regarding the booster dose benefits to increase its acceptance.

11 December 2022 in Infectious Disease Reports
Verified
Journal Article
Open access
PDF file
Harapan HarapanHarapan Harapan
Harapan Harapan
Malik SallamMalik Sallam
Malik Sallam
RFRaisha Fathima
Raisha Fathima
HKHendrix Indra Kusuma
Hendrix Indra Kusuma
SASamsul Anwar
Samsul Anwar
Mudatsir MudatsirMudatsir Mudatsir
Mudatsir Mudatsir
Willingness to pay (WTP) for booster doses of coronavirus disease 2019 (COVID-19) vaccines is an under studied research topic. Therefore, the current study aimed to investigate the WTP for the booster doses of COVID-19 vaccines and its predictors in Indonesia using an online survey distributed all over the provinces of this low-middle-income country. The WTP was evaluated using a basic dichotomous contingent valuation approach, and its associated determinants were evaluated using a linear regression model. Out of 2935 responders, 66.2% (1942/2935) were willing to pay for a booster dose of the COVID-19 vaccine. The majority of respondents (63.5%) were willing to pay within a price range of 100,000–500,000 Indonesian rupiah (IDR), i.e., USD 6.71–33.57. Being older than 40 years, having a higher educational level, having a higher income, knowing and understanding that booster doses were important, and having a vaccine status that is certified halal (permissible in Islamic law), were all associated with a higher WTP for the booster dose of COVID-19 vaccines. The study findings imply that the WTP for a booster dose of COVID-19 vaccination in Indonesia is lower compared to acceptance of vaccines provided free of charge. This WTP data can be utilized to develop a pricing scheme for the booster doses of COVID-19 vaccination in the country with potential benefits in other low-income countries. The government may be required to provide subsidies for the herd immunity vaccination process to proceed as anticipated. Furthermore, the public community must be educated on the importance of vaccination as well as the fact that the COVID-19 epidemic is far from being over.

1 September 2023 in Journal of Korean Neurosurgical Society
Verified
Journal Article
Open access
PDF file
ASAndre Marolop Pangihutan Siahaan
Andre Marolop Pangihutan Siahaan
STSteven Tandean
Steven Tandean
BNBahagia Willibrordus Maria Nainggolan
Bahagia Willibrordus Maria Nainggolan
JTJunita Tarigan
Junita Tarigan
JSJohan Samuel Sitanggang
Johan Samuel Sitanggang
Dengue fever is the most rapidly spreading mosquito-borne virus in the world, infecting about 100 million individuals. A rare but possibly dangerous consequence of dengue illness is intracranial hemorrhage (ICH). Currently, the pathogenesis of ICH is unknown. A number of studies have found a variety of risk factors for ICH in dengue. In addition, studies have reported the use of emergency surgery while monitoring thrombocytopenia in the therapy of dengue ICH. This review enumerates the potential predictors of ICH in dengue, discusses the use of brain imaging, and mentions the possibility of emergency surgery.

15 December 2023 in Surgical Neurology International
Verified
Journal Article
Open access
ASAndre Marolop Pangihutan Siahaan
Andre Marolop Pangihutan Siahaan
BNBahagia Willibrordus Maria Nainggolan
Bahagia Willibrordus Maria Nainggolan
MSMartin Susanto
Martin Susanto
RIRr Suzy Indharty
Rr Suzy Indharty
STSteven Tandean
Steven Tandean
The big black brain (BBB) phenomenon is described as an infant’s response to an acute subdural hematoma (SDH). It is characterized by hypodensity and swelling of the supratentorial compartment as a whole.

1 February 2024 in World Journal of Oncology
Verified
Journal Article
Open access
PDF file
NFNadya Keumala Fitri
Nadya Keumala Fitri
BNBahagia Willibrordus Maria Nainggolan
Bahagia Willibrordus Maria Nainggolan
NFNaufal Nandita Firsty
Naufal Nandita Firsty
APAndika Pradana
Andika Pradana
DSDina Keumala Sari
Dina Keumala Sari
The Addition of Atezolizumab to Chemotherapy in Non-Small Cell Lung Cancer: A Trial-Based Review and Meta-Analysis

16 September 2022 in Surgical Neurology International
Verified
Journal Article
Open access
ASAndre Marolop Pangihutan Siahaan
Andre Marolop Pangihutan Siahaan
STSteven Tandean
Steven Tandean
BNBahagia Willibrordus Maria Nainggolan
Bahagia Willibrordus Maria Nainggolan
Background: Trauma is the most frequent reason for epidural bleeding. However, numerous investigation had discovered that anticoagulants such as rivaroxaban could cause epidural hematoma. Here, we present a case of epidural hematoma in young man who got rivaroxaban as treatment of deep vein thrombosis. Case Description: A 27-year-old male with a history of deep vein thrombosis and one month of rivaroxaban medication presented with seizure and loss of consciousness following a severe headache. A CT scan of the head revealed epidural bleeding, and emergency blood clot removal was performed. As a reversal, prothrombin complex was utilized. Conclusion: Rivaroxaban has the potential to cause an epidural hemorrhage. Reversal anticoagulant should be administered before doing emergency surgery.